
(Reuters) -The U.S. Food and Drug Administration said on Friday that it will convene a panel of experts on January 22, 2026, to review an request by Swedish Match USA, a unit of Philip Morris International, to market its ZYN nicotine pouches as lower-risk alternatives to cigarettes.
The advisory committee will examine modified-risk applications for 20 ZYN products, each sold in 3-mg and 6-mg strengths.
The FDA in January 2025 cleared the same 20 products for sale after reviewing them under its premarket system for new tobacco products, allowing them to remain on the U.S. market.
That decision did not allow Swedish Match to claim the products reduce disease risk.
Swedish Match USA now wants permission to use the statement: "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis."
The panel will discuss data on how the products compare with cigarettes in terms of health risks, how consumers might understand and react to the proposed claim, and what effect such marketing could have on overall public health.
Sales of Zyn have surged in recent months, with shipments in the Americas jumping 38% year-over-year in the third quarter of 2025, while sales of traditional cigarettes continue to fall significantly.
The FDA's review will determine whether the scientific and legal standards are met for marketing ZYN as a modified-risk tobacco product.
It will issue a final order either granting or denying the application after the advisory committee's deliberations.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Tasim Zahid)
latest_posts
- 1
The most effective method to Promoter for Cellular breakdown in the lungs Mindfulness in Your People group - 2
Truly amazing Palaces: Which Is Your Number one? - 3
The Force of Positive Reasoning: Day to day Attestations - 4
Gym tied to outbreak of obscure disease that spreads through mist - 5
Well known Travel Booking Locales: What's Your Pick?
Merz visit highlights new strategic, and strained, Germany-Israel bond
A Time of Careful Eating: Individual Tests in Nourishment
CDC studies show value of nationwide wastewater disease surveillance, as potential funding cut looms
Free Fuel Giveaway Sparks Traffic Mayhem Before Police Shut It Down
Instructions to Upgrade the Proficiency of Your Sunlight powered chargers
Former biotech CEO sued over COVID vaccine alleged insider trading
SUVs Known for Their Looks As opposed to Their Capacity
What is IDF's view on pontential long-term occupation of southern Lebanon?
'Hero' who wrestled gun from Bondi shooter named as Ahmed al Ahmed













